TD Cowen Reiterates Buy Rating on Allstate (ALL)

TD Cowen analyst Andrew Kligerman reiterated a Buy rating and $224.00 price target on Allstate (NYSE: ALL).

The analyst commented, "In response to a competitor report, we reiterate ALL's (1) ability to post target underwriting profitability (including target expense ratios amidst higher marketing); (2) solid capital levels, including estimated $2.5B-$3.5B from the sale of its health businesses; (3) increased agent productivity to offset decreased count; and (4) robust policy-in-force growth potential."

For an analyst ratings summary and ratings history on Allstate click here. For more ratings news on Allstate click here.

Shares of Allstate closed at $185.36 yesterday.

You May Also Be Interested In

• Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
• Howard Hughes Holdings to join S&P SmallCap 600 on Oct. 28
• Raymond James Reiterates Strong Buy Rating on Alnylam Pharmaceuticals (ALNY)